The need for treatments to correct an immunological defect, or to restore an impaired
immune response associated with disease or ageing, has led to the development of …

The clinical need for therapeutic agents designed to augment immune responsiveness in
patients with deficient or depressed resistance has led to an increased interest in cellular …

Levamisole, a simple chemical first introduced as a broad spectrum anthelmintic, is an
immunotherapeutic compound with anti-anergic properties. The present work summarizes …

Levamisole (LEV) is a drug with a dual career. Originally introduced as an anthelminthic
agent in the mid-1960s, it soon revealed itself as a compound capable of increasing …

Study of the effects of the anthelmintic durg levamisole on human monocyte function in vitro
reveals that this drug enhances functional capacities. Monocytes demonstrate increased …

Cell-mediated immunity is a requirement for recognition and elimination of cells and for
prevention or treatment of a variety of diseases. Therefore, the development of a product …

The immunopotentiating drug, levamisole, was found to augment human lymphocyte
responses to allogeneic cells and plant mitogens in vitro. The effect was critically dose …

Skip the header click to show the menu Menu Cart Login Login/Register Institutional Access
Access Options Enter words / phrases / DOI / ISBN / keywords / authors / etc Search Advanced …

Although originally designed as an anthelmintic and still being used as such, levamisole has
become one of the most intriguing compounds in current medicine. The unravelling of its …

The clinical need for agents to modify immune response in the treatment of patients with
cancer has lead to an increased interest in cellular and biochemical mechanisms regulating …